MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-31-2025
Bio-Rad Laboratories EV/EBITDA Ratio 2011-2026 | BIO
Annual EV/EBITDA Ratio Bio-Rad Laboratories
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 34.5 | 40 | 29.5 | 22.4 | 27.9 | 21.2 | 12.4 | 11.1 | 11.9 | 9.1 | 7.33 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 40 | 7.33 | 20.7 |
EV/EBITDA Ratio of other stocks in the Medical devices industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
-0.915 | - | -26.83 % | $ 2.62 M |  USA |
 |
LivaNova PLC
LIVN
|
215 | $ 69.84 | 1.14 % | $ 3.79 B |  Britain |
 |
Allied Healthcare Products
AHPI
|
367 | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-244 | - | - | $ 1.77 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
23 | $ 6.61 | 3.44 % | $ 475 M |  Israel |
 |
Apollo Endosurgery
APEN
|
-7.33 | - | - | $ 475 M | USA |
 |
Lianluo Smart Limited
LLIT
|
-50.1 | - | 24.59 % | $ 44.8 M |  China |
 |
Alphatec Holdings
ATEC
|
-8.6 | $ 13.85 | -0.57 % | $ 2.08 B | USA |
 |
Avinger
AVGR
|
-2.46 | - | -20.74 % | $ 369 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-4.23 | - | -5.86 % | $ 30.6 M | USA |
 |
AxoGen
AXGN
|
-19.1 | $ 31.25 | -3.85 % | $ 1.44 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-36 | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-4.45 | - | 1.37 % | $ 20.5 M | USA |
 |
Apyx Medical Corporation
APYX
|
-29.2 | $ 3.46 | -2.26 % | $ 120 M | USA |
 |
Conformis
CFMS
|
-44.1 | - | - | $ 16.4 M | USA |
 |
BIOLASE
BIOL
|
-86.3 | - | -13.19 % | $ 166 K | USA |
 |
EDAP TMS S.A.
EDAP
|
730 | $ 4.63 | 3.58 % | $ 173 M |  France |
 |
Bruker Corporation
BRKR
|
-2.13 | $ 39.92 | 0.38 % | $ 5.95 K | USA |
 |
BioSig Technologies
BSGM
|
-1.88 | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
25.2 | $ 74.02 | -1.5 % | $ 110 B | USA |
 |
CryoLife, Inc.
CRY
|
49.1 | - | -4.14 % | $ 702 M | USA |
 |
ClearPoint Neuro
CLPT
|
-9.73 | $ 15.18 | 4.3 % | $ 410 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
0.013 | - | 1.15 % | $ 34.5 M | USA |
 |
CONMED Corporation
CNMD
|
40.2 | $ 46.01 | -0.07 % | $ 1.43 B | USA |
 |
Soliton, Inc.
SOLY
|
-14 | - | -1.42 % | $ 435 M | USA |
 |
Cardiovascular Systems
CSII
|
-93.5 | - | 0.15 % | $ 844 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
90.3 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-38.6 | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
-12 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-20.2 | - | - | $ 111 M |  Canada |
 |
InMode Ltd.
INMD
|
23.3 | $ 13.96 | -0.14 % | $ 902 M | Israel |
 |
Cutera
CUTR
|
236 | - | -10.19 % | $ 1.99 M | USA |
 |
Delcath Systems
DCTH
|
-1.69 | $ 10.16 | 2.11 % | $ 290 M | USA |
 |
Intersect ENT, Inc.
XENT
|
-12.1 | - | - | $ 955 M | USA |
 |
Dynatronics Corporation
DYNT
|
-2.59 | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-1.15 | - | - | $ 10.2 M | USA |
 |
Electromed
ELMD
|
26.4 | $ 23.53 | 1.64 % | $ 199 M | USA |
 |
Second Sight Medical Products
EYES
|
3.87 | - | -0.97 % | $ 54.4 M | USA |
 |
Establishment Labs Holdings
ESTA
|
-68.6 | $ 77.39 | -2.87 % | $ 2.18 B |  Costa-rica |
 |
Nano-X Imaging Ltd.
NNOX
|
-0.00869 | $ 2.46 | 1.23 % | $ 144 M | Israel |
 |
GBS
GBS
|
1.03 | - | -0.57 % | $ 7.12 M | USA |
 |
FONAR Corporation
FONR
|
-33.4 | $ 18.54 | -0.16 % | $ 122 M | USA |
 |
Globus Medical
GMED
|
27.6 | $ 95.57 | 3.99 % | $ 12.9 B | USA |
 |
Profound Medical Corp.
PROF
|
-7.43 | $ 7.35 | 2.79 % | $ 180 M | Canada |
 |
Helius Medical Technologies
HSDT
|
-0.0925 | $ 2.18 | 17.84 % | $ 1.33 M | USA |
 |
IRadimed Corporation
IRMD
|
46 | $ 100.38 | 1.3 % | $ 1.27 B | USA |
 |
Invacare Corporation
IVC
|
1.89 | - | - | $ 24.7 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
29.6 | $ 11.54 | 0.09 % | $ 889 M | USA |
 |
Inogen
INGN
|
17.4 | $ 6.07 | 3.94 % | $ 144 M | USA |